BioSpace News Archive

The Janssen Pharmaceutical Companies of Johnson & Johnson announced new three-year data from the long-term extension of the STELARA® Phase 3 UNIFI study.

OSE Immunotherapeutics announced a €10 million payment corresponding to the first tranche of the financing granted by the European Investment Bank.

Astellas Pharma Inc. and Seagen Inc. announced the U.S. Food and Drug Administration granted PADCEV® regular approval in the U.S., in addition to approving a new indication for adult patients with locally advanced or metastatic urothelial cancer who are ineligible for cisplatin-containing chemotherapy and have previously received one or more prior lines of therapy.

Surgical robots play a vital role in surgery, particularly in handling surgical devices precisely over small incisions for different surgical procedures.

Nabriva Therapeutics plc, a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced that it has granted non-statutory stock options to purchase an aggregate of 2,250 ordinary shares of Nabriva Therapeutics as an inducement to a newly-hired employee.

Adamas Pharmaceuticals, Inc. announced that the compensation committee of the company’s board of directors granted four new employees restricted stock units to acquire 44,500 shares of the company’s common stock.

Oryzon Genomics, S.A. presented today preliminary data from the Phase II trial ESCAPE on vafidemstat’s ability to reduce the inflammatory response in COVID-19 patients.

Immunexpress , Inc. today announced a late-breaking presentation, titled “Use of SeptiCyte RAPID to assess the risk of ICU admission in COVID-19 patients” (ID#4984), demonstrating the performance of SeptiCyte® RAPID in triaging COVID-19 patients at the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), taking place virtually from July 9-12, 2021.

Foghorn Therapeutics Inc. today announced that Adrian Gottschalk, President & Chief Executive Officer, is scheduled to participate in a panel at the William Blair Biotech Focus Conference 2021, which is being held virtually from July 14-15.

Eurofins (Paris:ERF), through its empowerDX subsidiary, and Rite Aid announce the launch of an over-the-counter, FDA-authorised[1], at-home COVID-19 PCR Test Kit.